Carlos E. Orantes, MBA, BS, Chief Executive Officer has more than 25 years of experience in the life sciences, contract research, and drug development arena. He was most recently the CEO of Clinical Research Investments, which included Accel Clinical Research, Populace Health, Vitalis Research and Clinical Trial Connections as subsidiaries. Carlos’s prior experience includes leadership roles at Frontage Laboratories, AVANZA Laboratories, Bridge Laboratories, Gene Logic and Covance Laboratories.
Carlos earned his Bachelor of Science degree in Biology at George Washington University and his Master of Business Administration degree from Old Dominion University. He is also a Six Sigma Black Belt.
Stacey Colado, Chief Operating Officer has 12+ years of experience in the clinical research industry and served last as President/CEO of Talem Clinical Consulting where she provided consulting services for large clinical research sites in the areas of site management, quality assurance, staff development and project management. Stacey is well versed in managing large multi-disciplinary clinical operations teams with extensive experience and knowledge in the areas of clinical operations and quality assurance. She has a Bachelor of Science in Nursing from Radford University and her Clinical Research Coordinator professional certification from the Association of Clinical Research Professionals.
Andrew J. Cutler, MD, Chief Medical Officer is board certified in both Psychiatry and Internal Medicine and has been conducting clinical research since 1993 at the University of Virginia, the University of Chicago and since 1996 in Central Florida. Dr. Cutler also speaks to professional and community audiences about the evaluation and treatment of mental illnesses such as ADHD, Bipolar Disorder (Manic-Depression), Major Depression, Anxiety Disorders and Schizophrenia.
Duane Miskelly, Chief Financial Officer has over 20 years of leadership experience in strategic planning and execution, business transformation, and operational improvement and served last as Chief Financial Officer (CFO) of Nephron Pharmaceuticals.
Duane’s diverse experience includes public entities and private equity, global sales and operations, rapid growth as well as turning around troubled businesses. He has a Bachelor of Science in Accounting from the University of Maryland and a Master of Business Administration from the University of Texas McCombs Business School.